InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-25.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Kalofonos Isabel, Directeur Commercial. Director active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. Activity tracked since 5 January 2026. The latest transaction was disclosed on 5 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
2,500 shares@ US$40.5950.0% of flowCommon StockSEC:0001628280-26-001230
2,500 shares@ US$40.590.0019% mcap50.0% of flowCommon StockSEC:0001628280-26-001230:0
2 of 2 declarations
About Kalofonos Isabel
Isabel Kalofonos serves as Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. She is responsible for the company's commercial strategy and business development. Isabel brings expertise in sales management and business strategy, enabling her to drive growth initiatives. Her role is essential for achieving Crinetics' performance objectives.
